Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

109
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
109
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

109
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
109
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

19.0K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
19.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Engineering Interferon-γ-Enhanced Chimeric Antigen Receptor Macrophages via Lipid-Assisted Polymeric Nanoparticles for Cancer Immunotherapy.

ACS nano·2026
Same author

Antidepressant and Anxiolytic Effects of Intranasal Curcumin in Parkinson's Disease Model Rats: Inhibition of Neuroinflammation and Oxidative Stress.

Chinese journal of integrative medicine·2026
Same author

Expert consensus on imaging diagnosis of human infection with avian influenza.

Quantitative imaging in medicine and surgery·2026
Same author

Implications and prospects of immunological and neuroimaging research in HIV-associated neurocognitive disorders.

Frontiers in neurology·2026
Same author

<i>In situ</i> induction of multivalent PD-L1 antibody secretion to enhance cancer immunotherapy.

Biomaterials science·2026
Same author

The SMAD-Pathway Mediates HMGB1-Induced Proliferation and Metastatic Progression in Cutaneous Squamous Cell Carcinoma Cells.

Annals of dermatology·2026

関連する実験動画

Updated: Mar 30, 2026

Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery
09:09

Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery

Published on: May 2, 2019

8.1K

アクティブ・ターゲッテッド siRNA 配送のための腫瘍の酸性感受性ポリマーベクター

Chun-Yang Sun1, Song Shen1, Cong-Fei Xu2

  • 1The CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Life Sciences and Medical Center, University of Science & Technology of China , Hefei, Anhui 230027, PR China.

Journal of the American Chemical Society
|November 17, 2015
PubMed
まとめ

新しいナノベクターは 腫瘍内の保護殻を切り離し siRNAの伝達を促進します このアプローチはPEGylationを克服する.

さらに関連する動画

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

17.2K
Porous Silicon Microparticles for Delivery of siRNA Therapeutics
08:31

Porous Silicon Microparticles for Delivery of siRNA Therapeutics

Published on: January 15, 2015

11.6K

関連する実験動画

Last Updated: Mar 30, 2026

Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery
09:09

Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery

Published on: May 2, 2019

8.1K
Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

17.2K
Porous Silicon Microparticles for Delivery of siRNA Therapeutics
08:31

Porous Silicon Microparticles for Delivery of siRNA Therapeutics

Published on: January 15, 2015

11.6K

科学分野:

  • 生物医学工学
  • ナノテクノロジー
  • 薬物の配達

背景:

  • siRNAベクターの表面PEGylationはタンパク質吸収とRESクリアランスを阻害するが,細胞の吸収を阻害する.
  • 刺激に反応し 殻から離れるナノベクターは 細胞内化を強化し 循環を延長する 解決策を提供します
  • 腫瘍の細胞外pH (pHe) は有望な刺激ですが,微妙なpHの違いのために敏感なシステムを設計することは困難です.

研究 の 目的:

  • 腫瘍を標的としたシRNAの全身輸送のための新しい酸感性ブリッジコポリマーを開発する.
  • 刺激に反応するナノベクターを作り 細胞の吸収を向上させながら 血流を維持する
  • siRNAベクトル性能に対するPEGylationの二重効果のジレンマを克服するために.

主な方法:

  • 単純な酸に敏感なブリッジコポリマーの開発
  • ポリエチレングリコール (PEG) コロナによるミセルプレックス配送システム (Dm-NP) の形成.
  • PEG分離のためのpH反応性結合と,増強された吸収のための細胞浸透ペプチドの組み込み.

主要な成果:

  • Dm-NPは,長期の循環とRES回避のために安定したPEGコロナを示した.
  • 腫瘍部位での酸性結合破裂はPEG脱離を誘発し,細胞をターゲットにすることが容易になりました.
  • PEGの除去時に細胞に浸透するペプチドの曝露は,細胞の吸収を著しく増加させた.
  • Dm-NPは腫瘍の蓄積を効果的にし,非小細胞肺がんの増殖抑制を強めた.

結論:

  • 開発されたDm-NPシステムは,長期の循環と標的細胞配送をうまくバランスをとります.
  • 刺激反応性PEG分離は,腫瘍におけるナノベクターの有効性を高めるための実行可能な戦略です.
  • このアプローチは,siRNAの配送とがん治療のための安全で効果的な方法を提供します.